Science Explorer Back to mapMap
Discussion
Researcher · AZ Sint-Jan · Belgium

Dominik Selleslag

Dominik Selleslag publishes mostly in Hematology, Genetics and Molecular Biology, on topics such as Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments and Hematopoietic Stem Cell Transplantation.

OpenAlex
World rank
#639,938
of 7,710,434 ranked researchers
Rank in Belgium
#5,713
of 67,186
Works
313
Citations
16k
Citations per work
49.7
h-index
53
i10-index 127Top 3.1% in Hematology
Dominik Selleslag

What does Dominik Selleslag research?

Dominik Selleslag's work is mostly in Medicine (68%), Biochemistry, Genetics and Molecular Biology (7%).

Health Sciences: 212 works · 67.7% of their workMedicine: 212 works · 67.7% of their workHematology: 121 works · 38.6% of their workGenetics: 35 works · 11.3% of their workPublic Health, Environmental and Occupational Health: 22 works · 6.9% of their workOncology: 20 works · 6.3% of their workEpidemiology: 14 works · 4.6% of their workEverything else: 79 works · 25.2% of their workLife Sciences: 22 works · 7.1% of their workBiochemistry, Genetics and Molecular Biology: 22 works · 7.1% of their workMolecular Biology: 22 works · 7.1% of their workTHEIR WORKDominik Selleslag313works
Life Sciences7%Health Sciences68%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine21267.7%
  2. Everything else7925.2%
    1. Biochemistry, Genetics and Molecular Biology227.1%
  1. 1Hematology39% of their works
  2. 2Genetics11% of their works
  3. 3Molecular Biology7% of their works
  4. 4Public Health, Environmental and Occupational Health7% of their works
  5. 5Oncology6% of their works
  6. 6Epidemiology5% of their works

Research topics

Which keywords describe Dominik Selleslag's research?

The keywords of their largest research topics: Prognostic Factors, Hematopoietic Stem Cells, Acute Myeloid Leukemia, AML, Minimal Residual Disease, BCR-ABL, Imatinib and Bone Marrow Niche.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Prognostic Factors2513 topics
  2. Hematopoietic Stem Cells2102 topics
  3. AML1531 topic
  4. Acute Myeloid Leukemia1531 topic
  5. Minimal Residual Disease852 topics
  6. BCR-ABL621 topic
  7. Imatinib621 topic
  8. Bone Marrow Niche571 topic
  9. Graft-versus-Host Disease571 topic
  10. Acute Lymphoblastic Leukemia551 topic
  11. Childhood Cancer551 topic
  12. Chronic Lymphocytic Leukemia431 topic
  13. Genomic Aberrations431 topic
  14. JAK2 Mutation391 topic
  15. Myelofibrosis391 topic
  16. Diagnosis Criteria301 topic
  17. International Myeloma Working Group301 topic
  18. HDAC Inhibitors221 topic
  19. Histone Deacetylases221 topic

Where does Dominik Selleslag work?

Dominik Selleslag's main affiliation in the publication record is AZ Sint-Jan, Belgium.

How many publications and citations does Dominik Selleslag have?

OpenAlex counts 313 works and 15,552 citations for Dominik Selleslag, an h-index of 53, ranking #639,938 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Dominik Selleslag. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.